• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.核糖核酸酶PARN控制特定微小RNA的水平,这些微小RNA有助于p53调控。
Mol Cell. 2019 Mar 21;73(6):1204-1216.e4. doi: 10.1016/j.molcel.2019.01.010. Epub 2019 Feb 12.
2
PARN Modulates Y RNA Stability and Its 3'-End Formation.PARN调节Y RNA稳定性及其3'末端形成。
Mol Cell Biol. 2017 Sep 26;37(20). doi: 10.1128/MCB.00264-17. Print 2017 Oct 15.
3
Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.端粒酶RNA降解的抑制可挽救由戴斯科林或PARN缺陷引起的端粒酶缺乏。
Nat Struct Mol Biol. 2016 Apr;23(4):286-92. doi: 10.1038/nsmb.3184. Epub 2016 Mar 7.
4
Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.聚腺苷酸特异性核糖核酸酶(PARN)介导端粒酶RNA组分的3'末端成熟。
Nat Genet. 2015 Dec;47(12):1482-8. doi: 10.1038/ng.3423. Epub 2015 Oct 19.
5
Identification of PARN nuclease activity inhibitors by computational-based docking and high-throughput screening.通过基于计算的对接和高通量筛选鉴定 PARN 核酸酶活性抑制剂。
Sci Rep. 2023 Mar 31;13(1):5244. doi: 10.1038/s41598-023-32039-z.
6
Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease.端粒酶 RNA 成熟动力学的破坏导致疾病。
Mol Cell. 2019 May 16;74(4):688-700.e3. doi: 10.1016/j.molcel.2019.02.033. Epub 2019 Mar 28.
7
PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.PAPD5 介导的 miR-21 的 3' 腺苷酸化和随后的降解在增殖性疾病中被破坏。
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11467-72. doi: 10.1073/pnas.1317751111. Epub 2014 Jul 21.
8
Poly(A)-specific ribonuclease sculpts the 3' ends of microRNAs.聚(A)特异性核糖核酸酶塑造 microRNAs 的 3' 末端。
RNA. 2019 Mar;25(3):388-405. doi: 10.1261/rna.069633.118. Epub 2018 Dec 27.
9
The PARN, TOE1, and USB1 RNA deadenylases and their roles in non-coding RNA regulation.PARN、TOE1 和 USB1 RNA 去腺苷酸化酶及其在非编码 RNA 调控中的作用。
J Biol Chem. 2023 Sep;299(9):105139. doi: 10.1016/j.jbc.2023.105139. Epub 2023 Aug 6.
10
Regulation of poly(a)-specific ribonuclease activity by reversible lysine acetylation.聚(A)特异性核糖核酸酶活性的可逆赖氨酸乙酰化调节。
J Biol Chem. 2020 Jul 24;295(30):10255-10270. doi: 10.1074/jbc.RA120.012552. Epub 2020 May 26.

引用本文的文献

1
Fine Regulation of MicroRNAs in Gene Regulatory Networks and Pathophysiology.基因调控网络与病理生理学中微小RNA的精细调控
Int J Mol Sci. 2025 Mar 21;26(7):2861. doi: 10.3390/ijms26072861.
2
Widespread mono- and oligoadenylation direct small noncoding RNA maturation versus degradation fates.广泛的单腺苷化和寡腺苷化决定小非编码RNA的成熟与降解命运。
bioRxiv. 2025 Mar 12:2025.01.31.635978. doi: 10.1101/2025.01.31.635978.
3
ncRNA Editing: Functional Characterization and Computational Resources.非编码RNA编辑:功能表征与计算资源
Methods Mol Biol. 2025;2883:455-495. doi: 10.1007/978-1-0716-4290-0_20.
4
The biogenesis and regulation of animal microRNAs.动物微小RNA的生物合成与调控
Nat Rev Mol Cell Biol. 2025 Apr;26(4):276-296. doi: 10.1038/s41580-024-00805-0. Epub 2024 Dec 19.
5
Hoyeraal-Hreidarsson syndrome: a case report of dyskeratosis congenita with a novel PARN gene mutation.霍耶拉尔-赫雷达尔松综合征:一例伴有新型PARN基因突变的先天性角化不良病例报告。
Ann Med Surg (Lond). 2024 Oct 16;86(12):7395-7397. doi: 10.1097/MS9.0000000000002661. eCollection 2024 Dec.
6
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.从血液系统恶性肿瘤中p53的调控到去调控:对诊断、预后和治疗的影响
Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9.
7
RNASE4 promotes malignant progression and chemoresistance in hypoxic glioblastoma via activation of AXL/AKT and NF-κB/cIAPs signaling pathways.RNASE4通过激活AXL/AKT和NF-κB/cIAPs信号通路促进缺氧性胶质母细胞瘤的恶性进展和化疗耐药性。
Am J Cancer Res. 2024 Sep 15;14(9):4320-4336. doi: 10.62347/UDBJ5986. eCollection 2024.
8
What goes up must come down: off switches for regulatory RNAs.上行下效:调控 RNA 的关闭开关。
Genes Dev. 2024 Aug 20;38(13-14):597-613. doi: 10.1101/gad.351934.124.
9
RNA-binding proteins and exoribonucleases modulating miRNA in cancer: the enemy within.RNA 结合蛋白和外切核酸酶在癌症中调节 miRNA:内部的敌人。
Exp Mol Med. 2024 May;56(5):1080-1106. doi: 10.1038/s12276-024-01224-z. Epub 2024 May 1.
10
Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3'-isoforms, displaying an altered expression in breast cancer.聚腺苷酸特异性核糖核酸酶(PARN)生成并调节miR-125a-5p 3'异构体,其在乳腺癌中表达发生改变。
Signal Transduct Target Ther. 2024 Apr 15;9(1):90. doi: 10.1038/s41392-024-01795-3.

本文引用的文献

1
PARN and TOE1 Constitute a 3' End Maturation Module for Nuclear Non-coding RNAs.PARN 和 TOE1 构成核非编码 RNA 的 3' 端成熟模块。
Cell Rep. 2018 Apr 17;23(3):888-898. doi: 10.1016/j.celrep.2018.03.089.
2
A pathology atlas of the human cancer transcriptome.人类癌症转录组病理学图谱。
Science. 2017 Aug 18;357(6352). doi: 10.1126/science.aan2507.
3
PARN Modulates Y RNA Stability and Its 3'-End Formation.PARN调节Y RNA稳定性及其3'末端形成。
Mol Cell Biol. 2017 Sep 26;37(20). doi: 10.1128/MCB.00264-17. Print 2017 Oct 15.
4
Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G/S phase transition.都铎蛋白-SN介导的人类细胞微小RNA核酸内切酶降解促进G/S期转换。
Science. 2017 May 26;356(6340):859-862. doi: 10.1126/science.aai9372.
5
Targeting RNA for processing or destruction by the eukaryotic RNA exosome and its cofactors.靶向RNA以便由真核RNA外切体及其辅助因子进行加工或降解。
Genes Dev. 2017 Jan 15;31(2):88-100. doi: 10.1101/gad.294769.116.
6
Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.TERC的转录后调控可逆转端粒疾病的分子特征。
J Clin Invest. 2016 Sep 1;126(9):3377-82. doi: 10.1172/JCI87547. Epub 2016 Aug 2.
7
MicroRNA Control of p53.微小RNA对p53的调控
J Cell Biochem. 2017 Jan;118(1):7-14. doi: 10.1002/jcb.25609. Epub 2016 Jun 3.
8
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.p53 通路:起源、癌症中的失活以及新兴治疗方法。
Annu Rev Biochem. 2016 Jun 2;85:375-404. doi: 10.1146/annurev-biochem-060815-014710. Epub 2016 May 4.
9
Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.端粒酶RNA降解的抑制可挽救由戴斯科林或PARN缺陷引起的端粒酶缺乏。
Nat Struct Mol Biol. 2016 Apr;23(4):286-92. doi: 10.1038/nsmb.3184. Epub 2016 Mar 7.
10
The RNase PARN-1 Trims piRNA 3' Ends to Promote Transcriptome Surveillance in C. elegans.核糖核酸酶PARN-1修剪piRNA的3'末端以促进秀丽隐杆线虫的转录组监测。
Cell. 2016 Feb 25;164(5):974-84. doi: 10.1016/j.cell.2016.02.008.

核糖核酸酶PARN控制特定微小RNA的水平,这些微小RNA有助于p53调控。

The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.

作者信息

Shukla Siddharth, Bjerke Glen A, Muhlrad Denise, Yi Rui, Parker Roy

机构信息

Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA.

Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80303, USA.

出版信息

Mol Cell. 2019 Mar 21;73(6):1204-1216.e4. doi: 10.1016/j.molcel.2019.01.010. Epub 2019 Feb 12.

DOI:10.1016/j.molcel.2019.01.010
PMID:30770239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6430647/
Abstract

PARN loss-of-function mutations cause a severe form of the hereditary disease dyskeratosis congenita (DC). PARN deficiency affects the stability of non-coding RNAs such as human telomerase RNA (hTR), but these effects do not explain the severe disease in patients. We demonstrate that PARN deficiency affects the levels of numerous miRNAs in human cells. PARN regulates miRNA levels by stabilizing either mature or precursor miRNAs by removing oligo(A) tails added by the poly(A) polymerase PAPD5, which if remaining recruit the exonuclease DIS3L or DIS3L2 to degrade the miRNA. PARN knockdown destabilizes multiple miRNAs that repress p53 translation, which leads to an increase in p53 accumulation in a Dicer-dependent manner, thus explaining why PARN-defective patients show p53 accumulation. This work also reveals that DIS3L and DIS3L2 are critical 3' to 5' exonucleases that regulate miRNA stability, with the addition and removal of 3' end extensions controlling miRNA levels in the cell.

摘要

PARN功能丧失突变会导致一种严重形式的遗传性疾病先天性角化不良(DC)。PARN缺乏会影响非编码RNA的稳定性,如人端粒酶RNA(hTR),但这些影响并不能解释患者所患的严重疾病。我们证明,PARN缺乏会影响人类细胞中众多miRNA的水平。PARN通过去除由多聚腺苷酸聚合酶PAPD5添加的寡聚(A)尾巴来稳定成熟或前体miRNA,从而调节miRNA水平,如果这些尾巴保留,则会招募核酸外切酶DIS3L或DIS3L2来降解miRNA。敲低PARN会使多种抑制p53翻译的miRNA不稳定,从而导致p53以Dicer依赖的方式积累增加,这就解释了为什么PARN缺陷患者会出现p53积累。这项研究还揭示,DIS3L和DIS3L2是调节miRNA稳定性的关键3'至5'核酸外切酶,3'末端延伸的添加和去除控制着细胞内miRNA的水平。